Cause for type II diabetes identified; growth hormone level may determine insulin resistance.BELMONT, Calif.--(BW HealthWire)--June 24, 1997--AMUR Pharmaceuticals, Inc. today announced that its research scientists led by Fred I. Chasalow, Ph.D., have found strong evidence correlating low levels of a growth hormone growth hormone or somatotropin (sōmăt'ətrō`pən), glycoprotein hormone released by the anterior pituitary gland that is necessary for normal skeletal growth in humans (see protein). like protein with development of type two diabetes. Evidence leading to the announcement came from several studies including one suggesting that children with growth hormone like protein deficiency tended to develop type two diabetes as adults. AMUR Chief Scientist and Chief Executive Officer Chasalow commented that the company was aggressively pursuing study of the hypothesis. If successful, AMUR would develop replacement hormone therapy Hormone therapy Treating cancers by changing the hormone balance of the body, instead of by using cell-killing drugs. Mentioned in: Breast Cancer, Thyroid Cancer hormone therapy with the protein. This approach would treat the cause of the disorder, rather than the symptoms. The announcement was made at the 5th Joint Meeting of the European Society for Pediatric Endocrinology Pediatric endocrinology (British: Paediatric) is a medical subspecialty dealing with variations of physical growth and sexual development in childhood, as well as diabetes and other disorders of the endocrine glands. and the Lawson Wilkins Pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. Endocrine Society held June 22-26, in Stockholm, Sweden. AMUR Pharmaceuticals, Inc., is a stage two development bio-pharmaceutical company. The company is privately held. Further information about AMUR may be obtained on the World Wide Web at AMUR.COM (1) (Computer Output Microfilm) Creating microfilm or microfiche from the computer. A COM machine receives print-image output from the computer either online or via tape or disk and creates a film image of each page. , or by contacting James Nikas, director of Business Development, at 415/596-1580. The information contained herein is meant purely for informational purposes. CONTACT: AMUR Pharmaceuticals, Inc. James Nikas or Dr. Fred I. Chasalow, 415/596-1580 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion